IN8BIO, INC. Increase (Decrease) in Accounts Payable
IN8BIO, INC. (INAB) reported Increase (Decrease) in Accounts Payable of $135.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- IN8BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$5.00K.
- IN8BIO, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $140.00K, a 24.73% decline year-over-year.
- IN8BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $105.00K.
- IN8BIO, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$175.00K.
- IN8BIO, INC. increase (decrease) in accounts payable for fiscal 2025 was -$80.00K.
- IN8BIO, INC. increase (decrease) in accounts payable for fiscal 2024 was -$535.00K.
- IN8BIO, INC. increase (decrease) in accounts payable for fiscal 2023 was -$981.00K, a 164.97% decline from fiscal 2022.
- IN8BIO, INC. increase (decrease) in accounts payable for fiscal 2022 was $1.51M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $135.00K 10-Q · filed 2026-08-06 | $240.00K derived: sum of 3 quarters · filed 2026-08-06 | $65.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $140.00K 10-Q · filed 2026-05-07 | $245.00K derived: sum of 2 quarters · filed 2026-05-07 | $70.00K derived: sum of 3 quarters · filed 2026-05-07 | -$126.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$70.00K derived: sum of 2 quarters · filed 2026-03-12 | -$266.00K derived: sum of 3 quarters · filed 2026-08-06 | -$80.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$371.00K derived: sum of 2 quarters · filed 2026-08-06 | -$185.00K 10-Q · filed 2025-11-06 | -$931.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$196.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$10.00K 10-Q · filed 2026-08-06 | -$756.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $186.00K 10-Q · filed 2026-05-07 | -$560.00K derived: sum of 2 quarters · filed 2026-05-07 | -$867.00K derived: sum of 3 quarters · filed 2026-05-07 | -$838.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$746.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.05M derived: sum of 2 quarters · filed 2026-03-12 | -$1.02M derived: sum of 3 quarters · filed 2026-03-12 | -$535.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$307.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$278.00K derived: sum of 2 quarters · filed 2025-11-06 | $211.00K 10-Q · filed 2025-11-06 | $411.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $518.00K 10-Q · filed 2025-08-07 | $718.00K derived: sum of 3 quarters · filed 2025-08-07 | $927.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $489.00K 10-Q · filed 2025-05-07 | $689.00K derived: sum of 2 quarters · filed 2025-05-07 | $898.00K derived: sum of 3 quarters · filed 2025-05-07 | $543.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $409.00K derived: sum of 2 quarters · filed 2025-03-13 | $54.00K derived: sum of 3 quarters · filed 2025-03-13 | -$981.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$146.00K derived: sum of 2 quarters · filed 2024-11-12 | -$1.18M 10-Q · filed 2024-11-12 | -$381.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.39M 10-Q · filed 2024-08-08 | -$590.00K derived: sum of 3 quarters · filed 2024-08-08 | $113.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$1.03M 10-Q · filed 2024-05-09 | -$235.00K derived: sum of 2 quarters · filed 2024-05-09 | $468.00K derived: sum of 3 quarters · filed 2024-05-09 | $317.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.50M derived: sum of 2 quarters · filed 2024-03-14 | $1.35M derived: sum of 3 quarters · filed 2024-03-14 | $1.51M 10-K · filed 2024-03-14 |
| 2022-09-30 | $703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $552.00K derived: sum of 2 quarters · filed 2023-11-09 | $710.00K 10-Q · filed 2023-11-09 | $349.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $7.00K 10-Q · filed 2023-08-10 | -$354.00K derived: sum of 3 quarters · filed 2023-08-10 | $60.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $158.00K 10-Q · filed 2023-05-12 | -$203.00K derived: sum of 2 quarters · filed 2023-05-12 | $211.00K derived: sum of 3 quarters · filed 2023-05-12 | $19.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $53.00K derived: sum of 2 quarters · filed 2023-03-30 | -$139.00K derived: sum of 3 quarters · filed 2023-03-30 | -$319.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $414.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $222.00K derived: sum of 2 quarters · filed 2022-11-10 | $42.00K 10-Q · filed 2022-11-10 | $77.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$372.00K 10-Q · filed 2022-08-12 | -$337.00K derived: sum of 3 quarters · filed 2022-08-12 | -$533.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$180.00K 10-Q · filed 2022-05-12 | -$145.00K derived: sum of 2 quarters · filed 2022-05-12 | -$341.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$161.00K derived: sum of 2 quarters · filed 2022-03-17 | -$160.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | -$196.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$195.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.00K 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |